Form D · Pharmaceuticals
Xoc Pharmaceuticals, Inc.
Los Gatos, CA · CIK 0001727192
Offering snapshot reported Jan 25, 2018 · SEC filing
- Reported sold
- $11M Offering amount: $31M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 12, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2018 | Initial | $10,981,580 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-304106
Source: Form D, filed Jan 25, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom Armer | Director |
| Scott Borland | Director, Executive |
| Timothy Nelson | Director |
| Frank Torti | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
15732 Los Gatos Blvd., #326
Los Gatos, CA, 95032
Los Gatos, CA, 95032